![]() Kinnov Therapeutics Kinnov Therapeutics is a company dedicated to the research and development of therapies against addiction. | Upstream Bio Upstream Bio is a clinical-stage biotechnology company that develops treatments for inflammatory diseases. | ![]() Apnimed Apnimed is a pharmaceutical company focused on pharmacologic therapies for obstructive sleep apnea (OSA) and related disorders. | |||
Founding Date | Founding Date 2009 | Founding Date 2015 | Founding Date N/A | Founding Date 2021 | Founding Date 2017 |
Type | Type Public | Type Public | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations Burnaby, CA HQ Porto, PT Manchester, GB | Locations Chuo City, JP HQ | Locations Orléans, FR HQ | Locations Waltham, US HQ | Locations Cambridge, US HQ |
Employees | Employees N/A | Employees 39 | Employees N/A | Employees 38 | Employees 854% decrease |
Valuation ($) | Valuation ($) 401.7 k | Valuation ($) 64.9 m | Valuation ($) N/A | Valuation ($) 1.3 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥463m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $2.9m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods ¥4.3m (FY, 2025) | Cost of goods N/A | Cost of goods $23m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit ¥458.7m (FY, 2025) | Gross profit N/A | Gross profit ($20.2m) (FY, 2025) | Gross profit N/A |
Net income | Net income ($7.1m) (FY, 2022) | Net income (¥298.4m) (FY, 2025) | Net income N/A | Net income ($143.4m) (FY, 2025) | Net income N/A |

SUSMED is a digital therapeutics (DTx) development business.
View company
Kinnov Therapeutics is a company dedicated to the research and development of therapies against addiction.
View companyUpstream Bio is a clinical-stage biotechnology company that develops treatments for inflammatory diseases.
View company
Apnimed is a pharmaceutical company focused on pharmacologic therapies for obstructive sleep apnea (OSA) and related disorders.
View company